No title
BACKGROUND: So far, the ImmuKnow Immune Cell Function Assay (Cylex, Inc., Columbia, MD, USA) has been used to assess risks of infection and rejection in transplant patients. We hypothesized that the ImmuKnow assay might be used for mortality screening in transplant patients overall.METHODS: In the period of February 2007 to December 2009, at the Uppsala University Hospital, 362 patients who receiv
